Cargando…

Study of the Visceral Adipose Tissue in a Cohort of Patients with Moderate-Severe Psoriasis Treated with Biological Therapy

INTRODUCTION: Visceral adipose tissue (VAT) has a greater relationship with the genesis of the metabolic syndrome and the pathology associated with obesity. METHODS: A cross-sectional study of patients with moderate-severe psoriasis in the Psoriasis Unit of the San Cecilio University Hospital in Gra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricardo, Ruiz-Villaverde, Ruiz-Carrascosa José, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824680/ https://www.ncbi.nlm.nih.gov/pubmed/35223176 http://dx.doi.org/10.5826/dpc.1201a32

Ejemplares similares

A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
por: Salgado-Boquete, Laura, et al.
Publicado: (2021)

Four years stability of type D personality in patients with moderate to severe psoriasis and its implications for psychological impairment()()
por: Aguayo-Carreras, Paula, et al.
Publicado: (2021)

PILOT STUDY OF SEXUAL DYSFUNCTION IN PATIENTS WITH PSORIASIS: INFLUENCE OF BIOLOGIC THERAPY
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
por: Molina-Leyva, Alejandro, et al.
Publicado: (2015)

Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Efficacy of several biological therapies for treating moderate to severe psoriasis: A network meta-analysis
por: Geng, Wenjun, et al.
Publicado: (2018)

Biological therapies in moderate and severe psoriasis: perspectives and certainties
por: Constantin, MM, et al.
Publicado: (2014)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Biological Determinants of Metabolic Syndrome in Visceral and Subcutaneous Adipose Tissue from Severely Obese Women
por: Osorio-Conles, Óscar, et al.
Publicado: (2022)

Subcutaneous adipose tissue & visceral adipose tissue
por: Mittal, Balraj
Publicado: (2019)

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
por: ZOZAYA, Néboa, et al.
Publicado: (2022)

THE MANAGEMENT OF MODERATE TO SEVERE PSORIASIS: A BIOLOGIC REVOLUTION
por: Skillen, LA, et al.
Publicado: (2018)

Moderate‐to‐Vigorous Physical Activity With Accelerometry is Associated With Visceral Adipose Tissue in Adults
por: Murabito, Joanne M., et al.
Publicado: (2015)

Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis
por: Dodero-Anillo, Jose Manuel, et al.
Publicado: (2022)

Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document
por: Belinchón Romero, Isabel, et al.
Publicado: (2021)

Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review
por: Belinchon Romero, Isabel, et al.
Publicado: (2023)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab
por: Brunner, P.M., et al.
Publicado: (2021)

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
por: Leonardi, Craig L., et al.
Publicado: (2022)

Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
por: Membrive-Jiménez, Cristina, et al.
Publicado: (2023)

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis
por: Membrive Jiménez, Cristina, et al.
Publicado: (2021)

Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2021)

Switches between biologics in patients with moderate‐to‐severe psoriasis: results from the French cohort PSOBIOTEQ
por: Curmin, R., et al.
Publicado: (2022)

Angiogenesis Associated With Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity
por: Ledoux, Séverine, et al.
Publicado: (2008)

Visceral adipose tissue in patients with COVID-19: risk stratification for severity
por: Chandarana, Hersh, et al.
Publicado: (2020)

Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
por: Amato, Marco Calogero, et al.
Publicado: (2014)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016)

T Regulatory Cells in the Visceral Adipose Tissues
por: Fooks, Allen N., et al.
Publicado: (2021)

Visceral Adipose Tissue and Different Measures of Adiposity in Different Severities of Diffuse Idiopathic Skeletal Hyperostosis
por: Harlianto, Netanja I., et al.
Publicado: (2021)

Infections in Patients Receiving Subcutaneous Biological Treatments for Moderate to Severe Psoriasis
por: Messori, Andrea, et al.
Publicado: (2015)

Moderate to severe psoriasis treatment challenges through the era of biological drugs
por: Vide, Júlia, et al.
Publicado: (2017)

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
por: Barker, Jonathan, et al.
Publicado: (2021)

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
por: Golhen, Klervi, et al.
Publicado: (2022)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
por: Ruggiero, Angelo, et al.
Publicado: (2023)

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis
por: Pereyra-Rodriguez, José-Juan, et al.
Publicado: (2021)

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
por: Maravilla-Herrera, Paulina, et al.
Publicado: (2023)

Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
por: Ayen-Rodríguez, Angela, et al.
Publicado: (2022)

An Update on the Role of Adipose Tissues in Psoriasis
por: Wong, Yisheng, et al.
Publicado: (2019)

Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites
por: Schlecht, Inga, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qcmf7ng3866onncud4vs8k2m96